Sigma Life Science releases breast cancer-specific knockout and knockin cell lines fo

[News]

Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich, today announced the expansion of its CompoZr® Oncology Disease Model portfolio with the release of the first in its collection of breast cancer-specific knockout and knockin cell lines for drug discovery and research.

More... (http://www.news-medical.net/news/20110722/Sigma-Life-Science-releases-breast-cancer-specific-knockout-and-knockin-cell-lines-for-drug-research.aspx)